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Blood cultures (BCs) are frequently performed in 
sick children either at initial presentation or during 
the course of hospitalisation following clinical 
deterioration. A positive BC result may help to 
determine the causative pathogen as well as guide 
appropriate antimicrobial therapy. [1] A recent audit of BCs among 
adult patients at G F Jooste Hospital, Cape Town documented 
high rates of contamination by coagulase-negative staphylococci 
(CoNS) over a 6-year period ranging from 4.6% to 9.3% per year. 
Furthermore, this study documented increasing antibiotic resistance 
of Gram-negative organisms.[2] 
Objective
To understand BC contamination rates and the spectrum of 
pathogenic organisms causing bloodstream infection in children, we 
audited the results of BCs performed at our hospital. This analysis 




A retrospective audit of BCs. The Research Ethics Committee of 
the University of Cape Town approved the study. Because this was a 
retrospective analysis, informed consent was not obtained.
Setting
Red Cross War Memorial Children’s Hospital (RCWMCH) is a 290-
bed tertiary hospital that serves the paediatric population of the City 
of Cape Town and the Western Cape Province and neighbouring 
provinces.
Data extraction
BCs performed at RCWMCH are processed at the National Health 
Laboratory Service (NHLS) microbiology laboratory at Groote 
Schuur Hospital (GSH). All BC results of specimens obtained at 
RCWMCH from 2008 until 2012 were extracted from the NHLS 
GSH database. All positive results were divided into recognisable 
pathogens and non-pathogens or contaminants, based on definitions 
established by the Centers for Disease Control and Prevention.[3]
Statistical analysis
The analysis included comparison of results, stratified according to 
age, i.e. <1 year and ≥1 year of age. Data were analysed using Epi 
Info version 3.5.1. Conventional descriptive methods were used to 
analyse the data. The Mantel-Haenszel χ2 test was used to compare 
categorical data. Relative risk (RR) was used to estimate the size of 
differences. A χ2 test for linear trend was used to evaluate trends over 
time. A p-value of <0.05 was considered statistically significant.
Results
During the 5-year period there were 110 938 admissions to the 
hospital, representing a mean ± standard deviation of 22 187.6±854.8 
admissions per year. A total of 47  677 BC specimens were taken, 
providing a BC specimen per hospital admissions ratio of 1:2.33. 
The proportion of BCs with non-pathogenic growth (contaminated 
specimens) ranged between 5.9% and 7.2% per year. There was 
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Background. Blood cultures (BCs) are frequently performed in sick children. A recent audit of BCs among adult patients documented high 
rates of contamination by coagulase-negative staphylococci (CoNS).
Objectives. To describe BC contamination rates and common pathogenic organisms causing bloodstream infection in children at a tertiary-
level children’s hospital.
Methods. BC results for children admitted to Red Cross War Memorial Children’s Hospital from 2008 to 2012 were extracted from the 
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per year (p=0.4). CoNS was the predominant isolate in 53.8% of all contaminated BCs. Children <1 year of age experienced higher contamination 
rates than children >1 year of age (8.7% v. 4.7%; relative risk 1.84; 95% confidence interval (CI) 1.71 - 1.97). Pathogenic organisms were isolated in 
6.2% (95% CI 6.0 - 6.4) of all BC specimens. Among Gram-positive organisms, the proportion of Streptococcus pneumoniae isolates declined from 
14.3% to 4.7% (p<0.00001), while there was a significant increase in Gram-negative organisms (51.8% - 57.9%; p=0.04) over the 5-year period. 
Klebsiella pneumoniae, the predominant Enterobacteriaceae isolated, decreased from 45.8% to 31.7% (p =0.004). 
Conclusion. This study identified unacceptably high BC contamination rates, emphasising the importance of collecting BC specimens under 
sterile conditions. 
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no significant trend in the frequency of 
contaminated specimens (χ2 for trend p=0.4) 
(Table 1). The proportion of contaminated 
specimens was higher in children <1 year 
(8.7%, 1  928/22  091 v. 4.7%, 1  215/25  586; 
RR 1.84; 95% confidence interval (CI) 1.71 
- 1.97). Non-pathogens were either Gram-
positive (94.8%) or Gram-negative (5.1%). 
CoNS was the predominant contaminant, 
accounting for 53.8% (1 792/3 143) of all non-
pathogenic growth. Among contaminants, 
children <1 year experienced a higher rate of 
CoNS growth (63.5% v. 46.7%; RR 1.36; 95% 
CI 1.27 - 1.46) (Table 1).
Overall, 6.2% (2 969/47  677; 95% CI 
for binomial proportion 6.0 - 6.4) of BC 
specimens yielded pathogenic organisms. 
The yield was lower in children ≥1 year 
of age (5.6% v. 6.9%; Mantel-Haenszel χ2 
p<0.00001) (Table 1). The most common 
pathogens are shown in Table 2. 
Gram-positive bacteria accounted for 
36.5% (1 083/2 969) of all pathogenic isolates. 
The proportion of pathogens caused by 
Gram-positive bacteria, with Staphylococcus 
aureus and Streptococcus pneumoniae being 
those most commonly isolated, declined 
from 41.6% in 2008 to 33.4% in 2012 (χ2 for 
trend p=0.003). S. aureus and S. pneumoniae 
accounted for 13.7% (407/2 969) and 10.4% 
(309/2 969) of all pathogenic isolates, 
respectively. There was no significant 
change in the annual proportion of S. aureus 
isolates over the 5-year period (χ2 for trend 
p=0.2). There was a progressive decline 
in the annual proportion of positive BCs 
due to S. pneumoniae, from 14.3% in 2008 
to 4.7% in 2012 (χ2 for trend p<0.00001). 
Enterococcus faecalis and E. faecium together 
were responsible for 5.2% (153/2 969) of all 
pathogens with the annual proportion of 
these isolates increasing from 4.6% in 2008 
to 7.3% in 2012 (χ2 for trend p=0.04).
Gram-negative bacteria accounted 
for 56.6% (1 679/2 969) of all pathogens 
(Table 2). The χ2 test for trend revealed a 
significant increase between 2008 and 2012 
(51.8% - 57.9%; p=0.04). Enterobacteriaceae 
dominated and accounted for 64% 
(1 074/1 679) of all Gram-negative patho-
genic isolates and 36.2% (1  074/2  969) of 
all pathogens. There was no significant 
change in the annual proportion of 
Enterobacteriaceae (χ2 for trend p=0.76). The 
dominant Enterobacteriaceae isolates were 
Klebsiella pneumoniae (41.8%), Escherichia 
coli (29.1%) and Serratia marcescens (10.4%). 
The annual proportion of Enterobacteriaceae 
infections caused by K. pneumoniae isolates 
decreased significantly from 45.8% in 2008 
to 31.7% in 2012 (χ2 for trend p=0.004). 
By contrast, an increasing trend was 
documented for S. marcescens from 3.4% in 
2008 to 14.9% in 2012 (χ2 for trend p=0.0003). 
The annual proportion of E. coli did not 
change significantly (χ2 for trend p=0.5). 
Acinetobacter baumannii was responsible 
for 20.3% (340/1  679) of all Gram-negative 
infections, isolates increasing annually from 
12.4% (42/338) in 2008 to 25.2% (82/325) in 
2011 (χ2 for trend p=0.0004) and declining to 
8.2% (19/232) in 2012. 
Fungi constituted 6.7% (200/2  969) of 
all pathogens, there being no significant 
change in the proportion annually (χ2 for 
trend p=0.1). 
Discussion
This analysis provided initial information 
about BC results and bloodstream infection 
at RCWMCH. Of concern is the high 
contamination rates of 5.9 - 7.2% per 
year, which are above international target 
contamination rates of 2 - 3%.[4] Similar high 
contamination rates were also documented 
in a recent adult study conducted in Cape 
Town.[2] Because of technical challenges 
associated with drawing blood from infants, 
contamination was predictably higher in 
this subgroup.[5] High contamination rates 
documented suggest that BC procedures were 
not standardised and sterility and optimal 
skin disinfection not uniformly practised. 
Standardisation of BC procedures is linked 
to improved pathogen yield when optimal 
blood volumes are collected.[1,6] A paediatric 
study completed in Kenya showed that the 
proportion of positive BCs increased with 
each additional millilitre of blood cultured.[7] 
To limit contamination, all healthcare facilities 
should institute standardised guidelines for 
BC procedures and ensure ongoing training 
and education for existing and, especially, 
new medical staff.
In this study, only 1 in every 16 BC 
specimens (6.2%; 95% CI 6.0 - 6.4) yielded 
a pathogenic isolate. Systematic reviews of 
bloodstream infections carried out in Africa 
and southeast Asia showed pathogen yields 
of 8.2% (3 527/43 130; 95% CI 7.9 - 8.4) 
and 6.6% (1 722/26 258; 95% CI 6.3 - 6.9), 
respectively.[8,9] The pathogen yield in this 
study was somewhat lower. One would expect 
a higher pathogen yield in our setting, as the 
aforementioned studies[8,9] were a reflection of 
community-acquired bloodstream infections 






Positive Pathogenic Non-pathogenic CoNS
All
2008 9 396 1 323 (14) 652 (6.9) 671 (7.1) 298 (3.2)
2009 11 187 1 367 (12.2) 707 (6.3) 660 (5.9) 311 (2.8)
2010 10 143 1 338 (13.2) 652 (6.4) 686 (6.8) 358 (3.5)
2011 9 108 1 217 (13.4) 557 (6.1) 660 (7.2) 429 (4.7)
2012 7 843 867 (11.1) 401 (5.1) 466 (5.9) 296 (3.8)
p-value* 0.00007 <0.00001 0.4 <0.00001
<1 
2008 4 759 791 (16.6) 364 (7.6) 427 (9) 288 (6.1)
2009 5 241 776 (14.8) 368 (7) 408 (7.8) 205 (3.9)
2010 4 920 832 (16.9) 387 (7.9) 445 (9) 263 (5.3)
2011 3 968 652 (16.4) 261 (6.6) 391 (9.9) 279 (7)
2012 3 203 409 (12.8) 152 (4.7) 257 (8) 190 (5.9)
p-value* 0.006 0.00001 0.7 0.008
>1 
2008 4 637 532 (11.5) 288 (6.2) 244 (5.3) 110 (2.8)
2009 5 946 591 (9.9) 339 (5.7) 252 (5.2) 106 (1.8)
2010 5 223 506 (9.7) 265 (5.1) 241 (4.6) 95 (1.8)
2011 5 140 565 (10.9) 296 (5.8) 269 (5.2) 150 (2.9)
2012 4 640 458 (9.9) 249 (5.4) 209 (4.5) 106 (2.3)
p-value* 0.2 0.1 0.8 0.1
CoNS = coagulase-negative staphylococci.
*χ2 for linear trend.
RESEARCH
920  December 2013, Vol. 103, No. 12  SAMJ
only, whereas our study included both 
community-acquired and hospital-acquired 
bloodstream infections. Several factors, 
including prior antibiotic administration 
and suboptimal blood volumes, may 
have contributed to this lower yield. The 
Integrated Management of Childhood Illness 
Programme advises that any seriously ill 
child requiring urgent referral to hospital 
should receive intramuscular ceftriaxone 
prior to transfer.[10] Many children referred 
from level 1 facilities would therefore have 
received parenteral antibiotics prior to BC. 
Furthermore, the selection of patients for BCs 
should be reviewed to ensure that BCs are 
used optimally. 
The dramatic decline in the culture of 
S. pneumoniae over time almost certainly 
reflects the effectiveness of the national 
pneumococcal immunisation programme 
and the declining paediatric HIV incidence. 
The 7-valent pneumococcal conjugate 
vaccine was introduced in April 2009 and 
in May 2011 was replaced with a 13-valent 
conjugate; between February and May 2012 a 
national pneumococcal ‘catch-up’ campaign 
targeted all children aged 18 - 35 months. 
Gram-negative bacteria were the 
dominant pathogens. Although the 
proportion of Enterobacteriaceae did 
not change significantly during the study 
period, interesting changes were observed 
within this pathogen family. In particular, 
a decline in the annual proportion of 
K. pneumoniae isolates and an escalation 
of the annual proportion of S. marcescens 
isolates were observed. The dramatic decline 
in the proportion of A. baumannii isolates 
in 2012 probably relates to improvements in 
infection control measures and in ventilator 
practice in the paediatric intensive care unit. 
Concerning the latter, the new practice is 
to discard ventilator tubing once used, the 
previous practice of sterilisation and re-use of 
tubing having been discontinued (Professor 
Andrew Argent, personal communication). 
There are limitations to our study. Firstly, 
there was no analysis of the antimicrobial 
resistance patterns of the pathogens isolated, 
which will be the focus of a future study. 
Secondly, the focus of this study was BC results 
generated in a tertiary-level paediatric facility, 
rendering the findings of this audit, particularly 
with regard to pathogen trends, potentially 
inapplicable to other paediatric settings 
with different patient illness profiles and 
antimicrobial selection pressures. However, 
high contamination rates were also recorded 
in BCs in adult patients at G F Jooste Hospital, 
suggesting that the problem is widespread and 
that attention should be directed at optimising 
BC procedures according to recently 
published recommendations.[1] Thirdly, due 
to the retrospective nature of the study, BC 
specimens with inadequate volumes could not 
be evaluated. 
In conclusion, this study identified 
unacceptably high contamination rates, 
emphasising the importance of collecting 
BC specimens under sterile conditions. 
Decreasing trends in Gram-positive 
organisms, in particular S. pneumoniae, and 
an increase among the Gram-negative group 
of organisms were demonstrated. 
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Table 2. Spectrum of common pathogens on blood culture
2008 2009 2010 2011 2012
Gram-positive, % 
Total, N 271 255 234 190 133
Streptococcus pneumoniae 34.3 36.4 26.5 22.1 14.3
Staphylococcus aureus 33.9 32.2 42.3 40.5 42.1
Streptococcus group B 6.3 5.1 6.8 5.8 4.5
Enterococcus faecium 4.8 7.1 3.4 5.3 11.3
Enterococcus faecalis 6.3 7.5 4.7 14.7 10.5
Gram-negative, % 
Total, N 338 408 376 325 232
Klebsiella pneumoniae 31.3 27.2 27.9 21.2 22
Escherichia coli 21.9 19.1 17 14.5 22
Acinetobacter baumannii 12.4 17.2 17.8 25.2 8.2
Serratia marcescens 2.4 7.1 7.4 7.1 10.3
Other, %
Total, N 43 43 43 42 36
Candida albicans 73.8 77.5 53.5 32.5 55.6
Candida parapsilosis 14.3 17.5 18.6 27.5 11.1
Candida krusei 4.7 - - 11.9 19.4
Candida lusitaniae - 5 4.7 2.4 -
Candida tropicalis 2.3 - 16.3 - 5.6
Candida dubliniensis - - 2.3 12.5 -
Mycobacterium tuberculosis complex 2.3 7 - 4.8 2.8
